Combat 0.2%+0.5% (Ophthalmic Solution)
5 ml drop: ৳ 120.00
Medicine Details
Category | Details |
---|---|
Generic | Brimonidine tartrate timolol maleate |
Company | General pharmaceuticals ltd |
Indications
- Reduction of elevated intraocular pressure (IOP) in patients with glaucoma or ocular hypertension
Pharmacology
- Comprised of Brimonidine Tartrate & Timolol Maleate
- Dual mechanism of action
- Decreases aqueous humor production
- Increases nonpressure dependent uveoscleral outflow
- Lowers IOP by reducing aqueous humor production
- Rapid onset of action
- Peak ocular hypotensive effect seen within two hours of administration
Dosage & Administration
- Instill 1 drop in the affected eye(s) twice daily
Interaction
- Specific drug interaction studies have not been conducted
Contraindications
- Hypersensitivity to any component of the product
- Bronchial asthma
- Severe chronic obstructive pulmonary disease
- Sinus bradycardia
- Second or third-degree atrioventricular block
- Overt cardiac failure
- Cardiogenic shock
Side Effects
- Allergic conjunctivitis
- Conjunctival folliculosis
- Conjunctival hyperaemia
- Eye pruritus
- Ocular burning or stinging
Pregnancy & Lactation
- No adequate and well-controlled studies in pregnant women
- Use during pregnancy only if potential benefit justifies potential risk to the fetus
- Timolol detected in human milk
- Unknown excretion of Brimonidine Tartrate in human milk
- Decision regarding nursing should consider the importance of the drug to the mother
Precautions & Warnings
- May be absorbed systemically
- Similar cardiovascular and pulmonary adverse reactions as systemic beta-blockers
- Exercise caution in treating patients with severe or unstable cardiovascular or pulmonary diseases
Use in Special Populations
- Safety and effectiveness in children below the age of 2 years have not been established
- No overall differences in safety or effectiveness observed between elderly and other adult patients
Therapeutic Class
- Drugs for miotics and glaucoma
Storage Conditions
- Store at a cool & dry place
- Protect from light
- Do not use longer than 30 days after the first opening of the bottle
- Keep out of the reach of children
Related Brands
- Twinor 0.2% + 0.5% (Ophthalmic Solution) - unido-pharmaceuticals-ltd
- Ocluma 0.2%+0.5% (Ophthalmic Solution) - pacific-pharmaceuticals-ltd
- Ticoma B OSD 0.2%+0.5% (Ophthalmic Solution) - opsonin-pharma-ltd
- Locoma 0.2%+0.5% (Ophthalmic Solution) - aci-limited
- Glumol Plus 0.2%+0.5% (Ophthalmic Solution) - globe-pharmaceuticals-ltd